Peptic ulcer disease in dyspeptic patients with ischemic heart disease: Search and treat?

Zeitschrift fur Gastroenterologie

Volumn 43, Issue 6, 2005, Pages 581-586

  Banić, Marko ^a   Sutlic Z ^a   Biocina B ^a   Kujundzic M ^a   Fabijanic D ^b   Ljubicic N ^c   Plesko S ^d   Buljevac, M ^a   Kardum, D ^a   Cabrijan Z ^a   Grgurevic I ^a   Urek, M ^a   Tadic M ^a   Hulak, V ^a   Petrovecki M ^e   Bedenikovic V ^a   Starcevic B ^a   Rotkvic I ^a  

^a University of Zagreb   (Croatia)

^b UNIVERSITY HOSPITAL SPLIT   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d Croatia   (Croatia)

^e UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Aspirin; Dyspepsia; Helicobacter pylori; Ischemic heart disease; NSAIDs; Peptic ulcer disease

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DYSPEPSIA; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HEMATEMESIS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MELENA; PEPTIC ULCER; POSTOPERATIVE CARE; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; STOMACH PAIN;

COMORBIDITY; CORONARY ARTERY BYPASS; CROATIA; DYSPEPSIA; GASTROSCOPY; MYOCARDIAL ISCHEMIA; PEPTIC ULCER; PREVALENCE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 21344446827     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858073     Document Type: Article

References (20)

1. Talley NJ, Zinsmeister AR, Schleck CD et al. Dyspepsia and dyspepsia subgroups: a population based study. Gastroenterology 1992; 102: 1259-1268
2. Bernersen B, Johnsen R, Straume B et al. Towards a true prevalence of peptic ulcer: the Sorreisa gastrointestinal disorder study. Gut 1990; 31: 989-992
3. Dixon MF. Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 7-10
4. Ljubičić N, Banić M, Kujundžić M et al. The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic polyps. Eur J Gastroenterol Hepatol 1999; 11: 727-730
5. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic ulcer disease. Lancet 2002; 359: 14-22
6. Lanas A. Fuentes J, Benito R et al. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther 2002; 16: 779-786
7. Strnad M, Presečki V, Babuš V et al. Epidemiology of Helicobacter pylori infection. Lijec Vjesn 2002; 124 (Suppl I): S5-S9
8. Talley NJ, Stanghellini V, Heading RC et al. Functional gastrointestinal disorders. Gut 1999; 45 (Suppl II): S37-S42
9. Aalyke C, Lauritsen JM, Hallas J et al. Helicobacter pylori and risk ulcer bleeding among users of non-steroidal anti-inflammatory drugs: a case control study. Gastroenterology 1999; 116: 1305-1309
10. Babus V, Strnad M, Presecki V et al. Helicobacter pylori and gastric cancer in Croatia. Cancer Lett 1998; 125: 9-15
11. Schenck J, Mueller CH, Luebbers H et al. Does gastroscopy induce myocardial ischaemia in patients with coronary heart disease. Endoscopy 2000; 32: 373-376
12. Bretagne JF, Quina MG. Helicobacter pylori and non-steroidal anti-inflammatory drugs. Curr Opin Gastroenterol 1999; 15 (Suppl 1): S61-S65
13. Cryer B, Feldman M. Effects of very low dose daily, long term aspirin therapy on gastric, duodenal and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999; 117: 17-25
14. Konturek JW, Konturek SJ, Stachura J et al. Helicobacter pylori-positive peptic ulcer patients do not adapt to aspirin. Aliment Pharmacol Ther 1998; 12: 857-864
15. Pounder R. Silent peptic ulceration: deadly silence or golden silence? Gastroenterology 1989; 96: 626-631
16. Sternby NH. Atherosclerosis and peptic ulcer. Bull WHO 1976; 53: 571-577
17. Greaves DR, Channon KD. Inflammation and immune responses in atherosclerosis. Trends Immunol 2002; 23: 535-541
18. Strachan DP, Mendall MA, Carrington D et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischaemic heart disease in the Cearphilly Prospective Heart Disease Study. Circulation 1998; 98: 1286-1290
19. Ge ZZ, Zhang DZ, Xiao SD et al. Does eradication of Helicobacter pylori alone heal duodenal ulcers? Aliment Pharmacol Ther 2000; 14: 53-58
20. Wolfe MM, Sachs G. Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology 2000; 118: S9-S31